If You Have Arthritis: The One Question Most Doctors Forget to Ask

For decades, arthritis treatment has focused almost exclusively on cartilage and inflammation. But a quieter conversation, happening in chiropractor offices and phytotherapy clinics, points to a different piece of the picture that most rheumatologists do not test for. Over 1.5 million bottles of one phytotherapist's formula have sold worldwide. A significant portion of those customers describe themselves as arthritis sufferers.

By Senior Health Editor · The Modern Health Report · Published this month

If you live with arthritis, you have probably heard the same explanation more times than you can count. Cartilage in your joints is wearing down. The body responds with inflammation. The joints, in turn, get stiff, achy, and harder to move. Anti-inflammatories. Physical therapy. Hot packs. In tougher cases, prescription medications. Mostly, the message is to manage it and live with it.

But there is another conversation, much quieter, happening at the edges of mainstream medicine. It centers on something most arthritis patients have never had tested. A substance circulating in the bloodstream that, when elevated, slowly deposits microscopic crystals in the joints. Crystals that, over years, can compound the stiffness and discomfort of arthritis.

The substance is called uric acid. Most people associate it with gout, the well-known inflammatory condition that flares in the big toe. But a growing body of evidence (and the experience of one phytotherapist who has worked on this problem for three decades) suggests uric acid plays a much quieter role in the daily experience of arthritis than the medical mainstream tends to credit.

What the arthritis conversation has been missing

The standard explanation for arthritis has remained essentially unchanged for forty years. Cartilage thins. Joints lose lubrication. The body inflames. There is nothing much to be done, the conversation continues, other than over-the-counter pain relievers, anti-inflammatories, and a shrug.

It is a tidy story. But it has never quite explained why two people with the same arthritis diagnosis, at the same age, can have radically different joint experiences. One manages with an occasional pill and a walk in the morning. The other struggles through every day. Cartilage thinning, on its own, does not account for that gap.

What might? According to the phytotherapist whose work prompted this piece, the answer often comes down to one quiet, decades-long process. The slow deposit of uric acid crystals in the joints, compounding whatever cartilage degeneration is already underway.

How one phytotherapist connected the dots to arthritis

In the early 1990s, a plant medicine specialist named Vincent Tones watched his wife struggle with what doctors had diagnosed as carpal tunnel syndrome. Sharp pains in her wrists. Tendons that felt compressed. The kind of nagging stiffness that turns ordinary tasks (opening a jar, brushing hair, holding a coffee cup) into small daily reminders of getting older.

Vincent had his own version. Gout, the inflammatory condition that flares up in the joints, usually starting in the big toe. He understood the textbook explanation. Uric acid crystallizes in the joint. The crystals irritate the tissue. The body sends inflammation in to fight back. Discomfort follows.

But the more Vincent studied it, the more he became convinced of something most physicians had not connected: the same crystallization process that caused his gout flares was happening, more quietly, in millions of other joints across millions of other people. People with stiff hands. Aching knees. Shoulders that no longer rotated like they used to.

Many of them had been told they had arthritis. Osteoarthritis, in particular. Or simply "joints that aren't what they used to be." Vincent's hypothesis was that the conventional explanation, while not wrong, was incomplete. Uric acid crystals were a piece of the arthritis picture that almost nobody was addressing.

"It's like sandpaper, literally grinding at the joint"

That is how Vincent describes what uric acid crystals do once they settle in. Not a metaphor for inflammation in the abstract, but a reasonably accurate description of what tiny, needle-shaped crystals do when they collect in joint tissue and the body tries to move that joint anyway.

The crystals usually start at the extremities. Toes. Fingers. Ankles. Wrists. Over time, as uric acid levels stay elevated, they migrate. Knees. Hips. Shoulders. The lower back. The neck.

It is not a fast process. That is part of why most people miss it. The change happens slowly enough that you mistake it for aging.

Why this matters specifically for arthritis sufferers

Conventional arthritis treatment focuses on managing inflammation and discomfort once they are already happening. Anti-inflammatories. Topical creams. In more advanced cases, prescription medications with their own list of side effects.

What that approach does not address, Vincent argues, is the upstream cause. If uric acid crystals are part of why the joint is inflamed in the first place, treating the inflammation without supporting the body's ability to clear the crystals is a little like mopping up water without turning off the tap.

The body has its own machinery for clearing uric acid. The kidneys filter it out. The urinary system carries it away. Hydration helps. Certain foods make the job harder (red meat, alcohol, sugar, organ meats). Certain herbs, used for centuries in traditional medicine, appear to support the process.

It was the last category that drew Vincent's attention.

Seven herbs, one tincture, no tart cherry

Most uric acid supplements on the market rely heavily on tart cherry. Vincent deliberately did not. He had spent years studying European phytotherapy, an approach to plant medicine that takes ingredients seriously the way a chemist takes a periodic table seriously. He wanted a formula built on what the plant kingdom had been doing for joint comfort for millennia.

The version he eventually arrived at draws on seven traditional botanicals, each chosen for a specific role.

The combination was first sold in South Africa under the Lifetones name. Within a few years, demand grew enough that distribution expanded beyond pharmacy chains and into the United States, where the formula is now produced under U.S. manufacturing standards.

To date, the company reports over 1.5 million bottles sold worldwide.

What an American chiropractor sees in his arthritis patients

One of the more interesting endorsements of the formula has come from Dr. Ignacio Gavaldon, a chiropractor based in the U.S. who began recommending it to patients dealing with stubborn joint discomfort. Many of those patients, he notes, had already received arthritis diagnoses and had not responded well to conventional approaches.

Doctor's note

"As a chiropractor, I see patients frustrated by the cycle of flare-ups. Lifetones provides a thoughtful, plant-based approach to supporting healthy uric acid levels that I feel confident recommending to my patients."

Dr. Ignacio "Nacho" Gavaldon, DC · Doctor of Chiropractic

Dr. Gavaldon's observation is structurally consistent with what Vincent had been seeing for years. When the body is supported in clearing uric acid, the downstream joint experience tends to improve. Not all at once. Not for everyone. But often enough, and meaningfully enough, that those who have tried it tend to stay on it.

A significant share of Lifetones customers describe themselves as arthritis sufferers. Five of them, in their own words:

Why this story is finally getting traction

For most of its history, the Lifetones formula sat quietly on pharmacy shelves in South Africa, recommended primarily by physiotherapists and chiropractors who had noticed something the broader medical community hadn't. The story did not travel particularly fast, because it did not fit neatly into any existing category. It wasn't a drug. It wasn't a "cure." It was a phytotherapy formula that supported a natural process in the body. That is not the kind of story a pharmaceutical marketing budget tends to amplify.

What changed, slowly, was the customers. People with arthritis diagnoses who had spent years assuming their stiff hands and achy knees were a permanent feature found that some of it was not. Joint comfort improved. Mobility returned. They told friends. The friends told their friends. The bottle count crept upward.

The formula is not, of course, a cure. Vincent is the first to say so. The brand's labeling makes the same point. What it does, by his account and by the structure of the ingredient list, is support the body in doing what it is already trying to do: clear uric acid, ease the burden on the joints, and let the underlying tissue recover its native function.

For the millions of adults living with arthritis who have been told the discomfort is just part of the diagnosis (the people who have learned to manage it and lower their expectations of what their joints can do), that may be the most useful information they have heard in a long time.